ReviewDiscover oncology2022

Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis.

Qing Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.